Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

December 01, 2006 (Vol. 26, No. 21)

Isolator Technologies Slowly Catching On

European Firms Are Leading the Pack in Provision and Adoption of Systems

  • Isolator technology is emerging, albeit slowly, as an alternative to classified space in the manufacture of pharmaceutical and biological products. Isolators’ principal value is a reduction in the need for classified space, which is expensive to build and manage. Baxter’s ( Halle, Germany, facility manufactures highly potent, sterile ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.